-
公开(公告)号:US20190000906A1
公开(公告)日:2019-01-03
申请号:US15742827
申请日:2016-07-07
申请人: BRAINON INC
发明人: Yongkoo KANG
IPC分类号: A61K36/53 , A61P21/00 , A23L33/105
CPC分类号: A61K36/53 , A23L33/105 , A23V2002/00 , A23V2200/316 , A23V2250/21 , A61K36/27 , A61K2300/00 , A61P21/00
摘要: The present invention relates to a composition, containing extracts of Dipsacus asperoides (Phlomis umbrosa Turcz) and Cynanchum wilfordii as active ingredients, for promoting exercise ability and/or muscle formation. The intake of the composition according to the present invention promotes motor performance ability, and is useful in the promotion of muscle development.
-
公开(公告)号:US20180193403A1
公开(公告)日:2018-07-12
申请号:US15742242
申请日:2016-07-06
IPC分类号: A61K36/9066 , A61K31/047 , A61K31/19 , A61K36/889 , A61K36/185 , A61K36/324 , A61K36/282 , A61K31/192 , A61K31/198 , A61K31/405 , A61K31/401 , A61K31/4172 , A61K36/23 , A61K31/352 , A61K31/05 , A61K31/015 , A61K31/01 , A61K31/045 , A61K36/07 , A61K36/074 , A61K36/48 , A61K31/20 , A23L33/105 , A23L33/115 , A23L2/52
CPC分类号: A61K36/9066 , A23L2/52 , A23L33/10 , A23L33/105 , A23L33/115 , A23V2002/00 , A61K31/01 , A61K31/015 , A61K31/045 , A61K31/047 , A61K31/05 , A61K31/19 , A61K31/192 , A61K31/198 , A61K31/20 , A61K31/352 , A61K31/401 , A61K31/405 , A61K31/4172 , A61K36/07 , A61K36/074 , A61K36/185 , A61K36/23 , A61K36/282 , A61K36/324 , A61K36/48 , A61K36/71 , A61K36/889 , A61P35/00 , A61K2300/00 , A23V2200/308 , A23V2200/316 , A23V2200/318 , A23V2200/324 , A23V2250/194 , A23V2250/20
摘要: Healthful supplements are described herein. For example, the supplements can include at least four of the following types of nutrients: an amino acid blend, a coconut extract, a vegetable glycerin extract, an alcohol blend, a cannabinoid blend, a hemp plant extract, a Boswellia serrata extract, a curcuma/turmeric blend, black cumin seed, an Artemisia ludoviciana extract, an Astragalus extract, a fenugreek extract, a mushroom extract blend, or any combination thereof.
-
公开(公告)号:US09961932B2
公开(公告)日:2018-05-08
申请号:US14897176
申请日:2013-06-10
申请人: N.V. Nutricia
IPC分类号: A23L33/175 , A23L33/155 , A23L33/19 , A23L33/21 , A23L33/00
CPC分类号: A23L33/30 , A23L33/155 , A23L33/175 , A23L33/19 , A23L33/21 , A23V2002/00 , A23V2200/316 , A23V2200/332 , A23V2250/284 , A23V2250/54252 , A23V2250/71
摘要: The invention pertains to the use of a composition comprising per serving between 50-300 kcal; between 10 g and 35 g proteinaceous matter; and at least 2.5 microgram vitamin D, for the manufacture of a nutritional product for (a) the treatment or prevention of muscle mass decrease, (b) stimulation of muscle mass increase; or (d) stimulating muscle mass preservation, in obese or overweight adults of at least 40 years of age participating in a weight loss program. The inventors surprisingly found that nutritional supplementation with a low-caloric composition rich in protein, particularly whey protein and leucine, compared to an iso-caloric control supplement without protein, synergistically leads to preservation of muscle mass during a weight loss program involving a hypocaloric diet and a resistance exercise program in overweight/obese older adult.
-
公开(公告)号:US09833487B2
公开(公告)日:2017-12-05
申请号:US12865995
申请日:2009-02-19
申请人: Dong-Suk Park , Myung Chul Yoo , Do-Young Choi , Hyung In Yang , Yong-Hyeon Baek , Jeong-Eun Huh , Kyoung Soo Kim , Yong-Baik Cho , In Ho Jung , Jong Hyun Hur , Jae Dong Lee
发明人: Dong-Suk Park , Myung Chul Yoo , Do-Young Choi , Hyung In Yang , Yong-Hyeon Baek , Jeong-Eun Huh , Kyoung Soo Kim , Yong-Baik Cho , In Ho Jung , Jong Hyun Hur , Jae Dong Lee
IPC分类号: A61K36/355 , A61K36/8964 , A23L33/105
CPC分类号: A61K36/355 , A23L33/105 , A23V2002/00 , A61K36/8964 , A61K2300/00 , A23V2250/21 , A23V2200/306 , A23V2200/316
摘要: In some embodiments, a composition for the treatment and inhibition or prevention of arthritic diseases includes an extract of mixed herbs, the mixed herbs including an active ingredient with Lonicera japonica THUNB and Anemarrhena asphodeloides BUNGE.
-
公开(公告)号:US20170333523A1
公开(公告)日:2017-11-23
申请号:US15673630
申请日:2017-08-10
申请人: Nestec S. A.
发明人: Denis BREUILLE , Daniel Ryan MOORE , Trent STELLINGWERFF , Etienne POUTEAU , Lionel Jean Rene BOVETTO
CPC分类号: A61K38/1709 , A23L33/19 , A23L33/30 , A23L33/40 , A23V2002/00 , A61K9/1075 , A61K35/20 , A23V2200/316 , A23V2250/54252
摘要: The present disclosure relates to a non-therapeutic use of whey protein micelles to enhance muscle protein synthesis in a subject. Further aspects are directed to food compositions comprising whey protein micelles to be administered to children, athletes, or elderly persons.
-
公开(公告)号:US20170319608A1
公开(公告)日:2017-11-09
申请号:US15662212
申请日:2017-07-27
发明人: Robert A. Settineri
IPC分类号: A61K31/702 , A61K31/661 , A61K9/00
CPC分类号: A61K31/702 , A23D9/013 , A23L29/10 , A23L29/244 , A23L33/105 , A23L33/115 , A23L33/12 , A23V2002/00 , A61K9/0056 , A61K9/006 , A61K31/05 , A61K31/122 , A61K31/16 , A61K31/375 , A61K31/385 , A61K31/522 , A61K31/593 , A61K31/66 , A61K31/661 , A61K31/683 , A61K31/685 , A61K31/7028 , A61K31/716 , A61K31/733 , A61K33/22 , A61K38/28 , A61K38/44 , A61K38/446 , A61K45/06 , A61K47/12 , A61K47/24 , A61K47/26 , A61P21/00 , A61P39/06 , C12Y111/01006 , C12Y115/01001 , A61K2300/00 , A23V2200/302 , A23V2200/316 , A23V2200/33 , A23V2250/184 , A23V2200/30 , A23V2250/1844 , A23V2250/1846 , A23V2250/1848 , A23V2250/185 , A23V2250/1852 , A23V2250/314 , A23V2250/5062 , A23V2250/7106 , A23V2250/714 , A23V2250/026 , A23V2250/708 , A23V2250/21
摘要: Composition, preferably, in the form of capsules or chewable wafers in quantities suitable for relieving the symptoms of fibromyalgia comprise formulations of phospholipids, specifically identified concentrations of phosphatidylglycerol, phosphatidic acid, phosphatidylethanolamine, phosphatidylcholine, glycolipids and phosphatidylserine along with inulin and other desirable active ingredients are described.
-
公开(公告)号:US09801404B2
公开(公告)日:2017-10-31
申请号:US14651423
申请日:2013-06-28
IPC分类号: A61K31/352 , A23L1/30 , A23L2/52 , A61K47/40 , A61K36/752 , A61K9/00 , A21D2/14 , A23L33/105
CPC分类号: A23L33/105 , A21D2/14 , A23L2/52 , A23V2002/00 , A61K9/0095 , A61K31/352 , A61K36/752 , A61K47/40 , A23V2200/316 , A23V2250/21162
摘要: An extract of Citrus depressa, preferably a water and/or organic solvent extract of a fruit of leaf of Citrus depressa, a supercritical extract of a fruit of leaf of Citrus depressa, or a subcritical extract of a fruit of leaf of Citrus depressa, which comprise 0.3 mass % or more of a polymethoxyflavonoid more than in terms of solid matter, for example, an extract of Citrus depressa comprising 0.2 mass % or more of nobiletin and/or 0.1 mass % or more of tangeretin in terms of solid matter, or a polymethoxyflavonoid such as nobiletin or tangeretin is used as an active ingredient of an IGF-1 production-promoting agent.
-
8.
公开(公告)号:US20170266130A1
公开(公告)日:2017-09-21
申请号:US15391462
申请日:2016-12-27
发明人: Suzy Cohen
IPC分类号: A61K31/10 , A61K9/48 , A61K9/20 , A23L33/10 , A61K38/39 , A61K36/324 , A61K31/728 , A61K36/906 , A61K9/00 , A61K33/04
CPC分类号: A61K31/10 , A23L33/10 , A23L33/105 , A23L33/17 , A23V2002/00 , A61K31/728 , A61K33/04 , A61K36/324 , A61K36/906 , A61K38/39 , A23V2200/316 , A23V2200/324 , A23V2250/21 , A23V2250/5422 , A61K2300/00
摘要: The present disclosure relates to a compound, method of making and method of using such compound preferably in the form of a dietary supplement. The composition, when administered, is capable of treating arthritis and various joint-related pain syndromes. The unique combination of the composition is preferably administered orally. A preferred composition is comprised of at least 10 to 200 mcg of selenium, from about 200 to 1200 mg of MSM, from about 100 to 900 mg of boswellia, from about 1 to 5 mg of type II collagen, from about 25 to 200 mg of hyaluronic acid, and from about 50 to 500 mg of ginger.
-
9.
公开(公告)号:US20170049736A1
公开(公告)日:2017-02-23
申请号:US15344835
申请日:2016-11-07
CPC分类号: A61K31/198 , A23K20/10 , A23K20/105 , A23K20/142 , A23K50/10 , A23L2/52 , A23L33/10 , A23L33/175 , A23P10/40 , A23V2002/00 , A61K9/0053 , A61K31/185 , A61K31/195 , A61K31/661 , A23V2250/306 , A23V2200/33 , A23V2200/316
摘要: The present invention is directed to an oral supplement including creatine hydrochloride, which has an aqueous solubility that is at least 15 times greater than creatine monohydrate, where the oral supplement drives significant improvements in muscle development and recovery due to its enhanced bio-availability, while causing fewer negative side effects compared to previous forms of creatine.
摘要翻译: 本发明涉及包含肌酸盐酸盐的口服补充剂,其水溶性度是肌酸一水合物的至少15倍,其中口服补充剂由于其增强的生物利用度而促进肌肉发育和恢复的显着改善,而 与以前的肌酸形式相比,引起的副作用较少。
-
公开(公告)号:US09554584B2
公开(公告)日:2017-01-31
申请号:US14069714
申请日:2013-11-01
IPC分类号: A23K20/142 , A23K1/16
CPC分类号: A23K20/142 , A23K20/105 , A23K20/147 , A23K20/30 , A23K50/40 , A23V2002/00 , A23V2200/332 , A23V2200/316 , A23V2250/063 , A23V2250/0628 , A23V2250/0632 , A23V2250/0616 , A23V2250/0638 , A23V2250/0652 , A23V2250/0624 , A23V2250/0606 , A23V2250/0626 , A23V2250/0648 , A23V2250/065 , A23V2250/0654 , A23V2250/1612 , A23V2250/0612
摘要: Compositions are provided comprising a balance between lysine and essential amino acids and metabolizable energy. The compositions are useful in methods to prevent or treat obesity in an animal without concomitant loss of lean muscle mass. The compositions may also be used in methods to preserve or to cause a gain in lean muscle mass in an animal in need thereof.
摘要翻译: 提供包含赖氨酸和必需氨基酸之间的平衡和可代谢能的组合物。 该组合物可用于预防或治疗动物中肥胖的方法,而不伴随瘦肌肉质量的损失。 组合物还可用于在有需要的动物中保留或引起瘦肌肉质量增加的方法。
-
-
-
-
-
-
-
-
-